Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates the initiation of ovarian cancer is by up-regulation of microRNA-378 via the ESR1 pathway to result in the down-regulation of a tumour suppressor called Disabled-2 (Dab2). Estrogen suppression of Dab2 was reproducible in vivo and across many cell types including mouse oviductal epithelium and primary cultures of human ovarian cancer cells. Suppression of Dab2 resulted in increased proliferation, loss of contact inhibition, morphological dysplasia, and resistance to oncogene-induced senescence -all factors that can sensitize OSE to transformation. Given that DAB2 is highly expressed in healthy human OSE and is absent in the majority of ovarian tumours, this study has taken the first steps to provide a mechanistic explanation for how estrogen therapy may play a role in the initiation of ovarian cancer.
Like all epithelial cells, OSE proliferation and morphology are tightly regulated by the asymmetrical distribution of polarity proteins that provide positional cues for surface localization and growth inhibition 14 . The mechanism by which E2 causes OSE dysplasia is unknown, but we predict that E2 action is mediated, at least in part, by inhibiting a tumour suppressor gene called Disabled-2 (Dab2). DAB2 is an adaptor protein that is critical for the polarized distribution of cell surface proteins (eg. CDH1) 15 , it regulates cellular response to growth control factors 16 , and it is highly expressed in normal human OSE but is lost in the majority of EOC 17, 18 . Immunohistochemical staining of DAB2 in prophylactic oophorectomy tissues consistently shows a transition of DAB2+ to DAB2-cells existing on the same ovary as the OSE layer transitions from a morphologically normal monolayer to morphologically dysplastic regions. These dysplasias are associated with preneoplastic features such as multicell-layered (papillary) epithelia, invaginations, and inclusion cysts 19 .
Dab2(−/−) knockout mice are embryonic lethal due to extensive disorganization of embryonic cells 20 . Dab2(+/−) are viable and only adult female mice display aberrant cellular morphology, which is limited to uterine hyperplasia and OSE dysplasia (oviduct morphology was not reported) 21 . Given the phenotypic similarities between ovaries of Dab2(+/−) mice and E2-treated mice, and the loss of DAB2 in preneoplastic human ovarian tissue, we hypothesized that E2 down-regulates Dab2 and prolonged exposure leads to epithelial disorganization and increased proliferation resulting in OSE dysplasia that could render them more susceptible to transformation. To elucidate the molecular mechanism by which E2 may sensitize normal cells to transformation, this study used primary cultures of mouse OSE cells as a model system. After the initial focus on OSE, we nevertheless demonstrated that the findings are physiologically relevant for mouse FTE in vivo and for human EOC cells.
Results
Prolonged exogenous E2 exposure causes dysplasia of the OSE monolayer. Mice that received exogenous E2 via subcutaneous insertion of an E2 pellet had increased areas of hyperplastic and columnar OSE relative to mice with placebo pellets (Supp. Fig. 1 ), as we have reported previously 5 . This dysplastic phenotype was reproduced in tissue culture plates by maintaining OSE cells in media containing 100 nM E2 for 15d ( Fig. 1 ). Quantification of proliferation using Ki67 staining verified that OSE cells displayed both increased number and proliferation of cells in response to E2 stimulation over 15d ( Fig. 1A-C ). Phase-contrast images showed that E2-treated cells formed foci of stratified cells on top of an underlying OSE monolayer after prolonged E2 exposure, whereas control cells remained as an organized monolayer ( Fig. 1D-F) . Foci of stratified cells were observable even in areas of sub-confluence in E2-treated dishes (Fig. 1F) , demonstrating that E2-treated OSE were not becoming stratified due to over-confluence, but more likely because the mechanisms conferring proper positional cues for formation of an organized monolayer were being deregulated with prolonged E2 stimulation.
OSE cell dysplasia is associated with a reduction in Dab2 expression and function. OSE cells exposed to continuous E2 showed a decrease in Dab2 expression in both animal and cell culture studies ( Fig. 2A-D) . IHC of ovaries from mice with E2 pellets showed loss of DAB2 associated with areas of OSE dysplasia ( Fig. 2A ). OSE cells exposed to E2 for 15d in culture also showed a reduction of Dab2 at the mRNA and protein levels ( Fig. 2B,C) . IF staining revealed that DAB2 is globally reduced in all E2-treated cells but cells aggregated in foci of stratified cells tend to have the greatest decrease in DAB2 compared to the surrounding monolayered cells ( Fig. 2D ). Since DAB2 has been shown to mediate the proper localization of CDH1 in mouse endoderm 15 , mouse ovaries and OSE cells were stained for CDH1 to determine if reduced Dab2 expression also correlates with its reduced function. It was clear that prolonged E2 exposure resulted in two distinct OSE phenotypes: (1) CDH1 expression is reduced, lost and/or mislocalized in areas of stratified cells; and (2) CDH1 expression is increased at the lateral membranes of columnar cells ( Fig. 2E ,F).
Dab2 suppression by E2 is via the ESR1 pathway and occurs before OSE dysplasia.
To determine if Dab2 suppression is due to direct E2 stimulation or is simply a result of dysplasia, OSE cultures were treated with E2 and suppression of DAB2 protein was observed by 48 h (Fig. 3 ). At this time, there were no changes in cell morphology or foci of stratified cells evident (Fig. 3A) . Therefore, Dab2 suppression occurs before the E2-induced dysplasia in OSE cells.
Esr2 transcripts were not detectable by qPCR analysis in cultured OSE cells (data not shown), suggesting that Dab2 suppression is primarily via the ESR1 pathway. To test this hypothesis, we isolated Esr1-floxed OSE from mice with conditional expression of Esr1. Esr1-WT OSE readily down-regulates DAB2 following 48 h of E2 exposure but Esr1-KO OSE showed no change ( Fig. 3B ). ESR1 degradation in E2-treated cells is consistent with its known mechanism of action where ESR1 degradation by the ubiquitin-proteasome pathway is required for efficient transcription of ESR1 target genes 22 . To determine if Dab2 suppression via the ESR1 pathway might be a more generalized mechanism, we used a different assay and cell type. MASE (mouse ovarian cancer) cells were pre-incubated with an ESR1 specific antagonist, MPP, for 1 h before treatment with E2 for 48 h. Similar to knockout of Esr1 in OSE cells, inhibition of ESR1 in MASE cells with MPP prevented DAB2 suppression by E2 ( Fig. 3C ). Interestingly, both knockout of Esr1 in OSE cells and inhibition of ESR1 by MPP in MASE resulted in a significant increase in DAB2 expression. This phenomenon was also independently observed in an ESR1-positive human breast cancer cell line where microarray data comparing control and ESR1 siRNA transfected MCF7 cells showed that knockdown of ESR1 significantly increased DAB2 expression ( Fig. 3D ). Lastly, to further investigate if E2 regulation of DAB2 is translatable to humans, EOC ascites cells were isolated and expanded in culture. Consistent with the results in mouse cells, DAB2 protein levels were maximally suppressed 48 h after E2 exposure ( Fig. 3E ). of Dab2 transcripts to less than 50% within 3 h of E2 exposure ( Fig. 4A ), suggesting a direct involvement of ESR1 in Dab2 suppression. Using chromatin immunoprecipitation, however, we found that upon E2 treatment, ESR1 did not bind to a putative estrogen response element in proximity to the transcription start site of Dab2 that is conserved in both mouse and humans 23 (Supp. Fig. 2 ). In light of these results, we investigated the possibility that Dab2 is suppressed by microRNAs (miRNAs) that are up-regulated by E2, since recent studies have demonstrated that E2 can regulate miRNA expression [24] [25] [26] , and that miRNAs can target the Dab2 transcript 27, 28 . miRNA microarray analysis comparing control vs. E2-treated MASE cells revealed that E2 regulates the expression of 110 miRNAs (Supp. Table 1 ). Of the miRNAs that had the highest increase in response to E2 (>2-fold change), miR-378 was the only miRNA that had a seeding sequence capable of targeting both human and mouse Dab2 transcripts (Supp. Fig. 3 ). Using qPCR analysis to validate the miRNA microarray results, we confirmed that miR-378 is up-regulated by E2 ( Fig. 4B ) and that this up-regulation is via the ESR1 pathway since E2 induction of miR-378 is not observed when MASE cells were pre-treated with an ESR1 antagonist ( Fig. 4C ). An E2 time-course experiment shows that E2 induction of miR-378 occurs within the same time frame as Dab2 transcript suppression ( Fig. 4A ,D) and using miRNA mimic assays, miR-378 was confirmed to be capable of suppressing DAB2 expression ( Fig. 4E) . Oncogene induced senescence (OIS) is a phenomenon observed in culture where untransformed cells will undergo senescence in response to increased oncogenic activity in an attempt to prevent the cell's progression into cancer 29 . To determine if loss of Dab2 would allow OSE to escape senescence and thereby sensitize them to transformation, Dab2-floxed OSE were infected with a KRAS G12D over-expression vector and assessed for senescence using X-gal stain. Consistent with the known ability of KRAS G12D to cause OIS, Dab2-WT OSE expressing KRAS G12D showed a significant increase in senescence-associated β-galactosidase (SA-βgal) activity while the percentage of senescent cells did not increase in Dab2-KO OSE (Fig. 5F ).
E2 suppresses

Dab2 suppression by E2 is observed in mouse FTE.
Prolonged estrogen usage has been shown to significantly increase the relative risk for epithelial EOC 4 , and with DAB2 loss observed in 85% of all EOC 17, 18 , this suggests that prolonged E2 exposure and Dab2 suppression may be relevant factors contributing to sensitizing the FTE to transformation as well. When mice were exposed to E2 for 60d, there were no changes in proliferation observed by Ki67 staining compared to placebo mice ( Fig. 6A ), but all segments of the FTE showed a significant decrease in DAB2 ( Fig. 6B ,D,E) and increased regions of dysplasia where we observed a significantly higher proportion of stratified FTE cells in the fimbria (Fig. 6D ) and hypertrophy of the FTE layer in the ampulla and isthmus (Fig. 6E ). It is possible for areas of stratified FTE cells to be observed as an artifact of histological sectioning due to the folding nature of the oviduct but blinded analysis of our tissue sections using the Aperio software confirms that E2-treated mice display a significantly higher proportion of dysplastic FTE relative to placebo mice ( Fig. 6C ). Similar to OSE cells, these results demonstrate that prolonged E2 exposure can lead to FTE dysplasia that is associated with DAB2 suppression. 
Discussion
In this study, we have demonstrated that primary cultures of OSE cells can replicate the E2-induced dysplasia observed in vivo and that OSE dysplasia occurs as a direct result of prolonged E2 exposure and not because of indirect E2 effects possibly occurring in vivo, such as altered gonadotropin secretion in the hypothalamic-pituitary-gonadal axis 5 . E2-induced OSE and FTE dysplasia can be linked to E2 suppression of Dab2 as loss of DAB2 alone results in increased cell proliferation, disorganization (including mislocalization of CDH1), and sensitization to transformation by escaping OIS. The ESR1 pathway mediates Dab2 suppression via E2 induction of miR-378, where Dab2 transcripts were significantly decreased within 3 h and maximal reduction in DAB2 protein was observed after 48 h. Finally, we have demonstrated that E2 suppression of Dab2 occurs both in vivo and in vitro, and across many cell types including mouse FTE and human ovarian and breast cancer cells. Moreover, it appears that Esr1 can regulate Dab2 in a ligand independent manner because in steroid hormone-free conditions, MPP inhibition of ESR1 or knockout of Esr1 alone was sufficient to increase DAB2 expression.
miRNA microarray analysis of E2 treated MASE has identified 110 miRNA candidates whose expression is altered by E2. Since our goal was to determine if miRNA up-regulation by E2 is a possible mechanism by which Dab2 can be decreased, we initially only focused on the top hit candidate miR-378, but it is nevertheless possible that Dab2 suppression is a combined effort among multiple miRNAs. Using KEGG pathway analysis, we discovered that the E2-regulated miRNAs in MASE are significantly associated with synthesis and metabolism of fatty acids, the Hippo signalling pathway (the main regulator of contact inhibition), and adherens junctions (Supp. Table 2 ). This is not surprising as E2 is known to play major roles in fatty acid metabolism and establishing the epithelial phenotype 30, 31 . This is the first time miR-378 is reported to be E2 inducible via the ESR1 pathway and a regulator of Dab2. Of the miRNAs that were increased >2-fold in our miRNA microarray, only miR-193b had been previously reported to be E2 regulated (in MCF7 cells) 26 . E2 regulation of miRNAs has been studied in multiple E2 responsive tissue types but little is known about E2 regulated miRNAs in ovarian epithelial cells.
Contact inhibition is a behaviour exhibited by epithelial cells to ensure proper formation of an epithelial monolayer by inhibiting cell proliferation upon contact with neighbouring cells. Loss of contact inhibition can result in outgrowth of cells from the epithelial monolayer 32 , much like the foci of stratified cells observed in our OSE model system. To determine if contact inhibition was disrupted by prolonged E2 exposure and Dab2 loss, sub-confluent vs. confluent OSE were stained with Ki67. While Dab2-WT and Dab2-KO OSE cells showed equal proportions of proliferating cells when sub-confluent, there was a notable difference in confluent cultures where Dab2-KO had a higher proportion of proliferating cells relative to Dab2-WT OSE. The results suggest that loss of DAB2 does not alter the rate of cell proliferation per se, but DAB2 appears to play an important role in mediating contact inhibition because loss of DAB2 causes a consequent failure to form a quiescent monolayer. Loss of Dab2 also had no apparent impact on CDH1 protein levels, but was responsible for its mislocalization. Mislocalization of CDH1 due to loss of Dab2 is likely a contributing factor to OSE dysplasia because cell adhesion mediated by CDH1 has been shown to be an initiator for contact inhibition 33 . It is important to note that loss of DAB2 did not completely mitigate the ability of OSE cells to be contact inhibited, because Dab2-KO OSE still show a reduction in Ki67 positive cells as they reach confluence -albeit not to the same extent as Dab2-WT OSE. This is not surprising because contact inhibition is mediated by the Hippo signalling pathway receiving input from multiple sources such as adhesion molecules (i.e.: Cdh1, Ctnna1, Ctnnb1) and growth factors (i.e.: EGFR) 32, 34 . KEGG pathway analysis of the MASE cell miRNA microarray data shows that E2 may be capable of contributing to Hippo signalling and adherens junction via miRNAs. To date, Dab2 has only been shown to regulate CDH1 and CTNNB1 localization 15, 35 .
A novel tumour suppressive role for Dab2 was discovered using Dab2-floxed OSE where loss of Dab2 allowed KRAS G12D over-expressing OSE cells to bypass OIS. KRAS G12D -induced senescence in untransformed cells is known to be due to activation of p53 36 , so it may be that DAB2 is able to impair KRAS G12D -induced p53 activation. Dab2 is speculated to have a genetic interaction with p53 where crosses between Dab2(+/−) and p53(−/−) mice resulted in sex biased embryonic lethality in females, but the mechanism by which this occurs has not been further investigated 21 .
Consistent with the phenotype of Dab2(+/−) mice, wherein the haploinsufficiency causes OSE dysplasia 21 , a 50% reduction in Dab2 expression by E2 treatment was sufficient to cause OSE cell dysplasia in vitro. This indicates that complete loss of DAB2 is not required for OSE dysplasia to occur. In vivo, this change in cell morphology required prolonged suppression of Dab2, as OSE dysplasia was not consistently observed in conditional Dab2(−/−) mice until they were 6 months old 37 . In contrast, mice treated with E2 pellets showed OSE dysplasia by 60d, perhaps due to additional effects of E2 that are independent of DAB2.
The role of DAB2 in normal ovarian function is unclear, but in addition to OSE dysplasia, conditional Dab2(−/−) female mice have significantly reduced reproductive capacity 37 . This is likely associated with the uterine dysplasias that develop in these mice, and indicates that DAB2 plays an important role in maintaining epithelial stability in many parts of the female reproductive tract. We speculate its regulation by E2 may be a regular phenomenon during the estrous cycle. Since OSE cell proliferation has been documented to occur only before 38, 39 , when E2 levels are highest, we hypothesize that transient Dab2 suppression during estrous would allow OSE cells to increase their proliferative capacity, despite the presence of neighbouring cells. Once E2 levels drop following ovulation, re-expression of Dab2 may play a role in re-establishing a quiescent OSE monolayer.
Little is known about the role of DAB2 in normal fallopian tube biology because previous studies investigating Dab2-KO mice were focused only on the ovary 21, 37, 40 . In humans, only one study has investigated DAB2 expression in non-malignant FTE cells but the authors acknowledged that their study may not reflect normal fallopian tube biology because their samples were from BRCA mutation carriers which may have altered steroid receptor activity 41 . Here, we demonstrated that prolonged E2 exposure reduced DAB2 expression and increased areas of FTE dysplasia -similar to the OSE layer. The E2-induced FTE dysplasia was comprised of two distinct phenotypes: increased areas of stratified FTE in the infundibulum and thickening of the FTE in the ampulla and isthmus regions. In the infundibulum, there is a high ratio of ciliated to secretory FTE cells and this ratio decreases as you move away from the ovary towards the uterus, such that secretory cells predominantly line the isthmus 42 . Although both secretory and ciliated cells express ESR1, the signalling pathways regulated by E2 in these cells remain unclear 43 . Our data shows that E2 treatment does not change the proportion of Ki67+ FTE cells in E2-treated mice relative to control, consistent with previous studies showing FTE cells do not proliferate in response to E2 or ovulation 44 . E2 however, is thought to play a role in regulating the structure and function of FTE cells, where it promotes the differentiation of ciliated cells and secretory cell activity 45, 46 . Studies observing porcine FTE in estrous conditions demonstrated that when E2 levels were high, FTE cells have increased height and demonstrate loss of cellular polarity relative to diestrous conditions where E2 levels are low 46 . Given that these two phenotypes are observable after 2.5d of high E2 conditions, it is not surprising that we observed increased FTE cell stratification and hypertrophy after exposing mice to E2 over 60d. Given DAB2's known function in regulating cell polarity, we would predict that the observed reduction of DAB2 in FTE cells is contributing to their dysplastic changes. The dysplastic changes associated with loss of DAB2, including loss of contact inhibition, increased proliferation, and escape from OIS are likely to render cells more susceptible to transformation [17] [18] [19] 21, 29 . This hypothesis is supported in human tissue where healthy normal OSE are DAB2+ and mostly Ki67-. As the OSE layer becomes dysplastic and progresses into cancer, the OSE becomes DAB2-and Ki67+ 17, 21 .
In post-menopausal women, estrogen therapy may be considered a double edged sword, for it can promote disease in the context of cancer but it is also important for maintaining women's health to reduce the incidence of diabetes, cardiovascular disease, and osteoporosis [47] [48] [49] . This study has taken the first steps to elucidate how prolonged estrogen exposure can sensitize normal healthy OSE and FTE to transformation to offer a mechanistic explanation for the epidemiologic evidence linking estrogen therapy to increased EOC risk. In the future, these model systems can be used to identify more genes associated with early epithelial dysplasia as potential targets to investigate for disease prevention and to mitigate the risk associated with hormone therapy.
Materials and Methods
Mice and E2 pellet implantation. Experiments involving mice were all performed according to the Canadian Council on Animal Care Guidelines for the Care and Use of Animals on a protocol approved by the University of Ottawa Animal Care Committee. E2-pellet implant and tissue collection were performed as previously described 5 . The 0.25 mg pellet results in a serum concentration of 2.75 nM E2. A combination of FVB/N and FVB/N × C57BL/6 mice were used in this study (placebo pellet, n = 3; E2 pellet, n = 3).
Immunohistochemical (IHC) staining of tissue. IHC was performed using a previously described protocol 50 . See Supp. Table 3 for details on antibodies used for IHC. Images were acquired using ScanScope CS2 (Leica Biosystems, Concord, Canada) and IHC quantifications were performed using the Aperio software (Leica Biosystems).
Cells in culture.
OSE cells were isolated from mouse ovaries and maintained in culture as previously described 51 . Esr1-floxed OSE were acquired from ovaries of Esr1 conditional knockout mice 52 and Dab2-floxed OSE were isolated from ovaries of Dab2 conditional knockout mice 37 . Dab2-floxed/KRAS G12D OSE were generated by infecting Dab2-floxed OSE with a Moloney based retroviral expression vector encoding KRAS G12D and hygromycin resistance. KRAS G12D expressing cells were selected using 2μg/mL hygromycin B (Sigma, Oakville, Canada). MASE EOC cells were isolated from ascites fluid of E2-treated tgCAG-TAg mice 5 . Human ascites cells (between passages 5-10) were acquired from the Ottawa Ovarian Cancer Tissue Bank from patients who consented to donate samples for research purposes.
Adenovirus infection of Esr1 and Dab2 conditional knockout OSE. Conditional knockout OSE cells
were suspended in serum-free αMEM medium and infected with AdGFP or AdCre (Baylor College, Houston, TX, USA) at 100pfu/cell. Infected cells were seeded into tissue culture plates and incubated at 37 °C for 1 h before FBS (10%) was added into the culture medium. Cells continued to incubate at 37 °C for 6 h, then fluid was replaced with fresh OSE medium 51 with 5% FBS. The next day, the media were replaced and the cells were left to recover from adenovirus infection for 1 week before use in experiments.
E2 treatment of cells in culture.
Cells were seeded into tissue culture plates such that cells would be 80-90% confluent by the end of the experiment. Cells were allowed to attach overnight in OSE media. The next day, cells were washed with PBS and the media was changed to steroid-free media consisting of 5% charcoal stripped FBS in phenol-red free DMEM-F12 (Sigma), 2ng/mL EGF (Sigma), and 0.01 mg/mL ITSS supplement (Roche, Indianapolis, IN, USA). Cells were allowed to normalize to steroid-free media for 48 h before treatment with 100 nM E2 or an equivalent volume of 100% EtOH (vehicle control). Media were refreshed every 3-4 d for 15 d experiments.
Assessment of cell proliferation. OSE cells were counted with a Vi-CELL Cell Counter (Beckman Coulter, Mississauga, Canada) 5, 10, and 15d after E2 treatment. Phase contrast images of cells during the experiment were acquired using an EVOS XL Core imaging system (Life Technologies, Burlington, Canada). 1 h prior to addition of 10 nM E2, MASE cells were pre-incubated with 1 μM methyl-piperidino-pyrazole (MPP) (Sigma), or an equivalent volume of DMSO (vehicle). Cells were lysed for protein isolation 48 h after E2 stimulation. microRNA (miRNA) mimic assays. Lipofectamine RNAiMax (Invitrogen, Carlsbad, CA, USA) reagent was used according to manufacturer's instructions to deliver 5, 10, or 20pmols of mirVana Mimics (ThermoFisher Scientific, Rockford, IL, USA) (Supp. Table 4 ) into MASE cells. Following transfection, cells were incubated for 2d at 37 °C before they were lysed for protein collection.
ESR1 inhibition.
Western blot analysis. Cells were lysed using M-PER (ThermoFisher Scientific) containing 1x protease inhibitor cocktail (Sigma). Protein samples were separated using NuPAGE Bis-Tris gels (ThermoFisher Scientific) and electro-transferred onto a PVDF membrane. Blots were blocked and probed as per standard protocol 53 and visualized using ECL Substrate (Bio-Rad, Mississauga, Canada) in an chemiluminescence AlphaImager imaging system (Protein Simple, San Jose, CA, USA). "Show Saturation" tool in the AlphaImager software was used to ensure blots used for analysis or figures were not over-exposed. See Supp. Table 3 for details on antibodies used for western blot. Amido Black stain (BDH Chemicals, Poole, England) was validated for use as western blot loading control 54, 55 . Image J software version 1.51o (NIH, Bethesda, MD, USA) was used for densitometric analysis of protein bands. Images generated for figures were processed in Adobe Photoshop where entire image was equally auto-contrasted then cropped to highlight bands of interest. Full-length blots are made available in Supp. Figs 6-9.
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Quantitative RT-PCR (qPCR) analysis. For mRNA analysis, mRNA was isolated from cells using an Illustra RNA extraction kit (GE Healthcare, Ottawa, Canada) and reverse-transcribed using an iScript cDNA Synthesis Kit (Bio-Rad). iTaq Universal Probes Supermix (Bio-Rad) with PrimeTime Probes (IDT, Coralville, IA, USA) or SsoFast EvaGreen Supermix (Bio-Rad) with primers (Invitrogen) was used to run qPCR analysis on the 7500Fast system (Applied Biosystems, Foster city, CA, USA). For miRNA analysis, miRNA was isolated from cells using a miRNeasy miRNA isolation kit (Qiagen, Toronto, Canada) and TaqMan MicroRNA assays (Applied Biosystems) were performed according to manufacturer's protocol to run qPCRs using the 7500Fast system. See Supp. Table 4 for miRNA assays and primers used for qPCR.
Immunofluorescence (IF) staining. Cells were seeded onto glass coverslips and treated with E2 for up to 15d as described above. Cells were fixed, permeabilized, blocked, and probed according to antibody datasheet instructions, then mounted onto slides using ProLong Gold mountant with DAPI (ThermoFisher Scientific). See Supp. Table 3 for details on antibodies used for IF. Wide-field IF images were acquired using a Zeiss Axioskop 2 microscope and confocal images were acquired using a Zeiss LSM 510 confocal microscope system (Zeiss, Toronto, Canada). Image J software was used to quantify Ki67 staining using the cell counter plugin. miRNA microarray. Data and details for miRNA microarray of MASE cells treated with E2 for 24 h (n = 3)
can be found on Geoprofiles: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98391. http://www. microrna.org was used for target prediction analysis.
Statistical analysis. Statistical analyses were performed using GraphPad Prism 5 (GraphPad software, La Jolla, CA, USA). One-way ANOVAs had significance determined with Dunnett's Multiple Comparison Test and two-way ANOVA had significance determined with a Bonferroni multiple comparisons post-test. All ANOVAs performed were with repeated measures test. T-tests were all two-tailed. All graphs show mean values and error bars represent the s.e.m.
Data availability.
The data that support the findings of this study are available from the corresponding author upon request.
